Literature DB >> 7458072

Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi.

A M Costrini, D A Mahler, W M Gross, J E Hawkins, R Yesner, N D D'Esopo.   

Abstract

We describe 19 cases of pulmonary disease due to Mycobacterium xenopi, a nosocomial infection related to the hospital water system. Pre-existing lung disease and prolonged environmental exposure during previous hospitalizations were apparent predisposing factors. Twelve patients had respiratory symptoms, including three with hemoptysis, at the time an abnormal chest roentgenogram was obtained. The predominant radiographic presentation of lung diseases caused by M. xenopi was a nodular or mass shadow, but cavitary disease and multiple nodular densities were also frequently observed. One subject had a solitary pulmonary nodule, and surgical resection was performed. In 12 patients who were skin tested with both M. xenopi sensitin and PPD-tuberculin, induration was consistently greater with M. xenopi. Initial isolates of M. xenopi were uniformly sensitive in vitro to 2.0 microgram of streptomycin, 1.0 microgram of isoniazid, and 10.0 microgram of para-aminosalicylic acid. In general, disease due to M. xenopi was successfully treated with standard antituberculosis drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7458072     DOI: 10.1164/arrd.1981.123.1.104

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  21 in total

Review 1.  Low dose inhaled corticosteroids and the prevention of death from asthma.

Authors:  J C Kips; R A Pauwels
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Post-operative acute respiratory failure associated with Mycobacterium xenopi.

Authors:  J M Rousseau; L Brinquin; Y Diraison; J P Bonsignour
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

5.  Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya.

Authors:  C F von Reyn; R D Waddell; T Eaton; R D Arbeit; J N Maslow; T W Barber; R J Brindle; C F Gilks; J Lumio; J Lähdevirta
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

6.  Mycobacterium xenopi isolation from clinical specimens in the Florence area: review of 46 cases.

Authors:  E Tortoli; M T Simonetti; C Labardi; A Lopes Pegna; E Meli; N Stanflin; S Susini
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

Review 7.  Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

Authors:  S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

8.  Mycobacterium avium complex, an emerging pathogen in Massachusetts.

Authors:  G C du Moulin; I H Sherman; D C Hoaglin; K D Stottmeier
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

9.  Pulmonary infection with mycobacterium xenopi: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

10.  Capillary gas chromatographic analysis of mycolic acid cleavage products, cellular fatty acids, and alcohols of Mycobacterium xenopi.

Authors:  M Luquin; F Lopez; V Ausina
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.